Meridian Bioscience Valuation
| VIVODelisted Stock | USD 33.97 0.00 0.00% |
At this time, the firm appears to be overvalued. Meridian Bioscience secures a last-minute Real Value of $28.28 per share. The latest price of the firm is $33.97. Our model forecasts the value of Meridian Bioscience from analyzing the firm fundamentals such as Profit Margin of 0.13 %, return on equity of 0.12, and Current Valuation of 1.39 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Meridian Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Meridian Bioscience is based on 3 months time horizon. Increasing Meridian Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Meridian Bioscience is useful when determining the fair value of the Meridian stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Meridian Bioscience. Since Meridian Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Meridian Stock. However, Meridian Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.97 | Real 28.28 | Hype 33.97 | Naive 34.3 |
The real value of Meridian Stock, also known as its intrinsic value, is the underlying worth of Meridian Bioscience Company, which is reflected in its stock price. It is based on Meridian Bioscience's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Meridian Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Meridian Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Meridian Bioscience helps investors to forecast how Meridian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Meridian Bioscience more accurately as focusing exclusively on Meridian Bioscience's fundamentals will not take into account other important factors: Meridian Bioscience Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Meridian Bioscience's current stock value. Our valuation model uses many indicators to compare Meridian Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Meridian Bioscience competition to find correlations between indicators driving Meridian Bioscience's intrinsic value. More Info.Meridian Bioscience is rated third in price to earning category among related companies. It is rated third in price to book category among related companies fabricating about 0.20 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Meridian Bioscience is roughly 5.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Meridian Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Meridian Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Meridian Bioscience's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Meridian Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Meridian Bioscience and how it compares across the competition.
About Meridian Bioscience Valuation
The delisted stock valuation mechanism determines the current worth of Meridian Bioscience on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Meridian Bioscience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Meridian Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Meridian Bioscience's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Meridian Bioscience's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Meridian Bioscience. We calculate exposure to Meridian Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Meridian Bioscience's related companies.Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 702 people.
8 Steps to conduct Meridian Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Meridian Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Meridian Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Meridian Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Meridian Bioscience's revenue streams: Identify Meridian Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Meridian Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Meridian Bioscience's growth potential: Evaluate Meridian Bioscience's management, business model, and growth potential.
- Determine Meridian Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Meridian Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Meridian Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Meridian Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 44 M | |
| Quarterly Earnings Growth Y O Y | -0.13 | |
| Forward Price Earnings | 40.6504 | |
| Retained Earnings | 223.2 M | |
| Retained Earnings Total Equity | 223.2 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets |